What began in 2012 at the initiative of the European Commission came to an end during the plenary session of April 5th, 2017, with the adoption by the European Parliament of the new regulations on Medical and In Vitro Diagnostic Medical Devices (MDR and IVDR).
Team NB, the European Association for Medical devices of Notified Bodies, in a note recently published on their website offers a sneak peek of the atmosphere surrounding the session: “There were for each text only one amendment tabled by Nigel Farage and the UKIP, was submitted, asking to reject the trilogue results. These amendments were rejected, which from a procedure point of view is a final endorsement of the text agreed by the Council in March and a closure of the second reading”. This was later confirmed by the acting European Parliament President Rainer Wieland.
In its Press release, the European Commission “welcomes the adoption of its proposal for two Regulations on medical devices which establish a modernised and more robust EU legislative framework to ensure better protection of public health and patient safety.”
The changes introduced by the new regulations focus on the following areas:
- Improve the quality, safety and reliability of medical devices
- Strengthen transparency of information for consumers
- Enhance vigilance and market surveillance
The final publication in the Official Journal for both regulations is expected within 4 to 6 weeks.
For Medical Device manufacturers, the adoption of the Medical Device Regulation (MDR) is a reminder that the transition will begin soon and last for 3 years; taking full effect by 2020. LNE/G-MED, a frontrunner for the designation under the new MDR and IVDR, will dedicate its next webinar to the changes introduced by both regulations. Stay tuned!